Xu et al. illustrated that GBP3 was overexpressed in glioblastoma and promoted tumor proliferation via activating the p62-ERK1/2 axis, and high GBP3 level diminished the sensitivity of glioblastoma to temozolomide treatment by enhancing DNA damage repair [47]. The gene discussed is MAPK3; the disease is glioblastoma.